Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke
Efficacy of Early Neuropsychological Rehabilitation and Family Psychoeducational Support After Ischemic Stroke: A Randomized 2×2 Factorial Clinical Trial With Blinded Outcome Assessment
1 other identifier
interventional
81
1 country
1
Brief Summary
Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke, and they also affect the patient's family, who often assume a caregiving role without preparation. Most rehabilitation trials begin three to four months after the acute event, and evidence about earlier intervention is scarce. This randomized clinical trial evaluates two independent interventions initiated 20 days after hospital admission: a structured computerized neuropsychological rehabilitation program for the patient, and a psychoeducational program for the main caregiver. A 2×2 factorial design allows the main effect of each intervention to be estimated within a single sample, as well as their potential interaction. The primary outcome is health-related quality of life at 3 months post-stroke, measured with the CAVIDACE scale and reported by the reference family member. Secondary outcomes include cognitive performance, functional status, mood and caregiver burden. Molecular biomarkers and structural neuroimaging variables are examined as exploratory prognostic factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2025
CompletedFirst Submitted
Initial submission to the registry
August 26, 2026
CompletedFirst Posted
Study publicly available on registry
August 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 20, 2027
August 28, 2026
August 1, 2026
1 year
August 26, 2026
August 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life (CAVIDACE total direct score)
Total direct score of the CAVIDACE scale (Quality of Life in Acquired Brain Injury), completed by the reference family member. Score range 0 to 192; higher scores indicate better quality of life. Analysed by ANCOVA adjusting for the baseline value at day 20 and for the randomization stratum.
3 months post-stroke (day 90 ± 14 days)
Secondary Outcomes (8)
Global neuropsychological composite score
3 months post-stroke
Modified Rankin Scale
3 months post-stroke
Barthel Index
3 months post-stroke
Lawton IADL Scale
3 months post-stroke
Caregiver burden (Zarit)
3 months post-stroke
- +3 more secondary outcomes
Other Outcomes (2)
Biomarks (BDNF, GFAP, IL-6, CRP, S100B)
3 months post-stroke
Neuroimaging
3 months post-stroke
Study Arms (4)
Group 1: Control
ACTIVE COMPARATORGroup 2: Neuropsychological rehabilitation
EXPERIMENTALGroup 3: Family psychoeducation
EXPERIMENTALGroup 4: Combined intervention
EXPERIMENTALInterventions
Structured computerized cognitive training program (Guttmann NeuroPersonalTrainer). 24 sessions of 45 minutes, twice weekly over 12 weeks, starting after randomization at day 20 post-admission.
Six individual 45-minute sessions delivered fortnightly by videoconference to the main caregiver, covering stroke information, the family role in recovery, emotional management, behavioral difficulties, cognitive therapy techniques and behavioral activation.
Simple recreational digital activities without adaptive difficulty, performance feedback or structured progression, matched in duration and frequency to the experimental program.
Informational leaflet on stroke, its consequences and available community resources, provided at hospital discharge.
Eligibility Criteria
You may qualify if:
- First-ever ischemic stroke (transient ischemic attack excluded)
- Age 18 years or older
- Prior functional independence (modified Rankin Scale ≤ 1)
- Diagnostic criteria for ischemic stroke (TACI, PACI, LACI, POCI)
- Capacity to provide informed consent, or availability of a legal representative
You may not qualify if:
- Previous neurological or psychiatric disease associated with cognitive impairment
- Severe systemic disease
- Life expectancy under one year
- Severe stroke (NIHSS score above 19 at admission)
- Alcohol or substance abuse (tobacco excluded)
- Clinically relevant aphasia preventing comprehension of test instructions Sensory impairment preventing neuropsychological assessment
- Functional illiteracy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia
Manresa, Barcelona, 08243, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jordi Sanchez Monteagudo, Doctorate Student
Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the interventions, participants, their family members and the professionals delivering the interventions cannot be blinded. Outcome assessors, laboratory personnel, the neuroimaging reader and the statistician are blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Neuropsychologist, Principal Investigator
Study Record Dates
First Submitted
August 26, 2026
First Posted
August 28, 2026
Study Start
November 19, 2025
Primary Completion (Estimated)
November 25, 2026
Study Completion (Estimated)
March 20, 2027
Last Updated
August 28, 2026
Record last verified: 2026-08